Lv1
4 积分 2026-01-28 加入
HER-2 Expression in Colorectal Cancer and Its Correlation with Immune Cell Infiltration
7小时前
待确认
Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
8小时前
已完结
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
8小时前
已完结
Advances in targeted therapy for esophageal cancer
9小时前
已完结
HER2-targeted therapies — a role beyond breast cancer
12天前
已完结
Pertuzumab in gastrointestinal cancer
15天前
已完结
Targeting HER2 expression in cancer: New drugs and new indications
15天前
已完结
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study
1个月前
已完结
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
1个月前
已完结
Function Regulation Assessment and Pathophysiological Dysfunction Repair of Oddi Sphincter
1个月前
已完结
皖公网安备34019202002308
